Header Logo

Connection

JOHN R STROEHLEIN to Male

Back to Details
This is a "connection" page, showing publications JOHN R STROEHLEIN has written about Male.
JOHN R STROEHLEIN
Connection Strength
0.153
Male
  1. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc. 2016 Aug; 84(2):315-25.
    View in: PubMed
    Score: 0.017
  2. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014 Oct 01; 120(19):3040-8.
    View in: PubMed
    Score: 0.015
  3. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med. 2013 Jun; 2(3):391-402.
    View in: PubMed
    Score: 0.014
  4. Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol. 2011 Jul; 137(7):1071-8.
    View in: PubMed
    Score: 0.012
  5. Adenocarcinoma of the small bowel: a 60-yr perspective derived from M. D. Anderson Cancer Center Tumor Registry. Am J Gastroenterol. 2006 Jul; 101(7):1647-54.
    View in: PubMed
    Score: 0.009
  6. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc. 2019 07; 90(1):116-124.
    View in: PubMed
    Score: 0.005
  7. Elusive case of dysphagia: Zenker's diverticulum masquerading as a cervical neoplasm. Endoscopy. 2019 03; 51(3):E63-E64.
    View in: PubMed
    Score: 0.005
  8. Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity? Inflamm Bowel Dis. 2019 01 10; 25(2):385-393.
    View in: PubMed
    Score: 0.005
  9. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. Eur J Gastroenterol Hepatol. 2019 01; 31(1):128-134.
    View in: PubMed
    Score: 0.005
  10. Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia. Gastrointest Endosc. 2019 05; 89(5):937-949.e2.
    View in: PubMed
    Score: 0.005
  11. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018 12; 24(12):1804-1808.
    View in: PubMed
    Score: 0.005
  12. Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflamm Bowel Dis. 2018 07 12; 24(8):1695-1705.
    View in: PubMed
    Score: 0.005
  13. Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson. J Immunother Cancer. 2018 05 11; 6(1):37.
    View in: PubMed
    Score: 0.005
  14. Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index. J Geriatr Oncol. 2018 01; 9(1):81-83.
    View in: PubMed
    Score: 0.005
  15. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018 07; 67(7):1299-1305.
    View in: PubMed
    Score: 0.005
  16. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc. 2015 Sep; 82(3):512-9.
    View in: PubMed
    Score: 0.004
  17. Age, affective distress, and illness detection in patients evaluated for gastrointestinal complaints. Psychosomatics. 1994 Mar-Apr; 35(2):125-31.
    View in: PubMed
    Score: 0.004
  18. Prostate cancer metastatic to the pancreas. J Clin Oncol. 2013 Jul 20; 31(21):e367-9.
    View in: PubMed
    Score: 0.004
  19. Iatrogenic infection of a colonic cystic lymphangioma following cold-forceps biopsy. Endoscopy. 2012; 44 Suppl 2 UCTN:E104-5.
    View in: PubMed
    Score: 0.003
  20. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol. 2010 May; 194(5):W401-6.
    View in: PubMed
    Score: 0.003
  21. Pustular psoriasis induced by infliximab. J Drugs Dermatol. 2004 Jul-Aug; 3(4):439-40.
    View in: PubMed
    Score: 0.002
  22. Diagnostic approach to evaluating the cause of a positive fecal occult blood test. CA Cancer J Clin. 1984 May-Jun; 34(3):148-57.
    View in: PubMed
    Score: 0.002
  23. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. Am J Clin Oncol. 1982 Aug; 5(4):421-7.
    View in: PubMed
    Score: 0.002
  24. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C. Lancet. 1980 Sep 06; 2(8193):534-5.
    View in: PubMed
    Score: 0.001
  25. Untreated gastric pseudolymphoma. Am J Dig Dis. 1977 May; 22(5):465-70.
    View in: PubMed
    Score: 0.001
  26. Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis. 1976 Oct; 21(10):841-4.
    View in: PubMed
    Score: 0.001
  27. Clindamycin-associated colitis. Mayo Clin Proc. 1974 Apr; 49(4):240-3.
    View in: PubMed
    Score: 0.001
  28. Chronic gastrointestinal bleeding in Von Willebrand's disease. Am J Surg. 1968 May; 115(5):727-9.
    View in: PubMed
    Score: 0.001
  29. Gastric heterotopia of the proximal esophagus: a report of four cases detected by endoscopy and review of literature. Am J Gastroenterol. 1986 Dec; 81(12):1162-6.
    View in: PubMed
    Score: 0.001
  30. Phase II trial of acivicin in patients with advanced colorectal carcinoma. Am J Clin Oncol. 1986 Jun; 9(3):189-91.
    View in: PubMed
    Score: 0.001
  31. Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices. Transplantation. 1986 Jan; 41(1):129-30.
    View in: PubMed
    Score: 0.001
  32. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary report. Am J Clin Oncol. 1983 Aug; 6(4):473-6.
    View in: PubMed
    Score: 0.000
  33. A comparative study of oral tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Apr; 6(2):181-6.
    View in: PubMed
    Score: 0.000
  34. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Apr; 6(2):187-90.
    View in: PubMed
    Score: 0.000
  35. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer. Am J Clin Oncol. 1983 Feb; 6(1):39-44.
    View in: PubMed
    Score: 0.000
  36. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Feb; 6(1):45-8.
    View in: PubMed
    Score: 0.000
  37. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Feb; 6(1):49-52.
    View in: PubMed
    Score: 0.000
  38. Work in progress: hypotension and high-volume biliary excretion following external percutaneous transhepatic biliary drainage. Radiology. 1982 Dec; 145(3):639-40.
    View in: PubMed
    Score: 0.000
  39. Phase II clinical evaluation of AZQ in colorectal cancer. Am J Clin Oncol. 1982 Oct; 5(5):535-7.
    View in: PubMed
    Score: 0.000
  40. Breath methane excretion in patients with unresected colorectal cancer. J Natl Cancer Inst. 1982 Sep; 69(3):573-6.
    View in: PubMed
    Score: 0.000
  41. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep. 1982 Aug; 66(8):1613-7.
    View in: PubMed
    Score: 0.000
  42. Chemotherapy for colorectal cancer with a combination of PALA and 5-FU. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):747-53.
    View in: PubMed
    Score: 0.000
  43. Hepatic artery infusion chemotherapy: gastroduodenal complications. AJR Am J Roentgenol. 1981 Aug; 137(2):347-50.
    View in: PubMed
    Score: 0.000
  44. Colorectal cancer in young adults. South Med J. 1981 Aug; 74(8):920-4.
    View in: PubMed
    Score: 0.000
  45. Gastric carcinoma in young adults. South Med J. 1979 Jun; 72(6):654-6.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.